BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19700667)

  • 1. Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface.
    Zloza A; Schenkel JM; Tenorio AR; Martinson JA; Jeziorczak PM; Al-Harthi L
    Blood; 2009 Oct; 114(18):3841-53. PubMed ID: 19700667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration of CD8+ T Cells into the Central Nervous System Gives Rise to Highly Potent Anti-HIV CD4dimCD8bright T Cells in a Wnt Signaling-Dependent Manner.
    Richards MH; Narasipura SD; Seaton MS; Lutgen V; Al-Harthi L
    J Immunol; 2016 Jan; 196(1):317-27. PubMed ID: 26582945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4
    Albalawi YA; Narasipura SD; Olivares LJ; Al-Harthi L
    J Virol; 2022 Aug; 96(15):e0080422. PubMed ID: 35852355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.
    Suni MA; Ghanekar SA; Houck DW; Maecker HT; Wormsley SB; Picker LJ; Moss RB; Maino VC
    Eur J Immunol; 2001 Aug; 31(8):2512-20. PubMed ID: 11500836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine peripheral blood CD4
    Rothe K; Bismarck D; Büttner M; Alber G; von Buttlar H
    Vet Immunol Immunopathol; 2017 Mar; 185():48-56. PubMed ID: 28242002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.
    Lhomme E; Richert L; Moodie Z; Pasin C; Kalams SA; Morgan C; Self S; De Rosa SC; Thiébaut R
    PLoS One; 2016; 11(4):e0152952. PubMed ID: 27124598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.
    Reguzova AY; Karpenko LI; Mechetina LV; Belyakov IM
    Expert Rev Vaccines; 2015 Jan; 14(1):69-84. PubMed ID: 25373312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
    Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
    Nyanhete TE; Frisbee AL; Bradley T; Faison WJ; Robins E; Payne T; Freel SA; Sawant S; Weinhold KJ; Wiehe K; Haynes BF; Ferrari G; Li QJ; Moody MA; Tomaras GD
    Sci Rep; 2019 Jul; 9(1):10165. PubMed ID: 31308388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 dim CD8 bright T cells are inversely associated with neuro-inflammatory markers among people with HIV.
    Albalawi YA; Shull T; Virdi AK; Subra C; Mitchell J; Slike BM; Jian N; Krebs SJ; Sacdalan C; Ratnaratorn N; Hsu DC; Phanuphak N; Spudich S; Trautmann L; Al-Harthi L
    AIDS; 2024 Jan; 38(1):1-7. PubMed ID: 37792358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral CD8
    Ranasinghe S; Lamothe PA; Soghoian DZ; Kazer SW; Cole MB; Shalek AK; Yosef N; Jones RB; Donaghey F; Nwonu C; Jani P; Clayton GM; Crawford F; White J; Montoya A; Power K; Allen TM; Streeck H; Kaufmann DE; Picker LJ; Kappler JW; Walker BD
    Immunity; 2016 Oct; 45(4):917-930. PubMed ID: 27760342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV.
    Zloza A; Sullivan YB; Connick E; Landay AL; Al-Harthi L
    Blood; 2003 Sep; 102(6):2156-64. PubMed ID: 12791668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of MHC class II-restricted CD8+CD4- and CD8-CD4- T cell responses to infection in CD4-/- mice.
    Pearce EL; Shedlock DJ; Shen H
    J Immunol; 2004 Aug; 173(4):2494-9. PubMed ID: 15294964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.